Visa Inc. (BKK:VISA06)

Aerovate Therapeutics Income Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Operating Revenue	38,893	35,926	32,653	29,310	24,105	21,846
Revenue	38,893	35,926	32,653	29,310	24,105	21,846
Revenue Growth (YoY)	11.38%	10.02%	11.41%	21.59%	10.34%	-4.92%
Cost of Revenue	863	778	736	743	730	727
Gross Profit	38,030	35,148	31,917	28,567	23,375	21,119
Selling, General & Admin	10,911	10,175	9,047	8,025	6,612	6,227
Other Operating Expenses	-	-	-	-	152	-
Operating Expenses	12,089	11,209	9,990	8,886	7,568	6,994
Operating Income	25,941	23,939	21,927	19,681	15,807	14,125
Interest Expense	-555	-641	-644	-538	-513	-516
Interest & Investment Income	818	992	745	69	-	80
Other Non Operating Income (Expenses)	14	14	18	88	25	-8
EBT Excluding Unusual Items	26,218	24,304	22,046	19,300	15,319	13,681
Merger & Restructuring Charges	-213	-	-	-	-	-
Gain (Loss) on Sale of Investments	-129	-44	-82	-296	747	120
Legal Settlements	-1,669	-462	-927	-868	-3	-11
Other Unusual Items	136	118	-	-	-	-
Pretax Income	24,343	23,916	21,037	18,136	16,063	13,790
Income Tax Expense	4,057	4,173	3,764	3,179	3,752	2,924
Net Income	20,286	19,743	17,273	14,957	12,311	10,866
Preferred Dividends & Other Adjustments	226	286	284	327	303	391
Net Income to Common	20,060	19,457	16,989	14,630	12,008	10,475
Net Income Growth	6.18%	14.30%	15.48%	21.49%	13.30%	-10.05%
Shares Outstanding (Basic)	1,843	1,882	1,903	1,936	2,121	2,134
Shares Outstanding (Diluted)	1,980	2,029	2,085	2,136	2,188	2,223
Shares Change (YoY)	-3.14%	-2.69%	-2.39%	-2.38%	-1.57%	-2.16%
EPS (Basic)	10.88	10.34	8.93	7.56	5.66	4.91
EPS (Diluted)	10.24	9.73	8.28	7.00	5.63	4.89
EPS Growth	9.62%	17.45%	18.31%	24.45%	15.11%	-8.07%
Free Cash Flow	22,083	18,693	19,696	17,879	14,522	9,704
Free Cash Flow Per Share	11.15	9.21	9.45	8.37	6.64	4.37
Dividend Per Share	2.360	2.150	1.870	1.575	1.335	1.220
Dividend Growth	13.46%	14.97%	18.73%	17.98%	9.43%	16.19%
Gross Margin	97.78%	97.83%	97.75%	97.47%	96.97%	96.67%
Operating Margin	66.70%	66.63%	67.15%	67.15%	65.58%	64.66%
Profit Margin	51.58%	54.16%	52.03%	49.91%	49.81%	47.95%
Free Cash Flow Margin	56.78%	52.03%	60.32%	61.00%	60.25%	44.42%
EBITDA	27,119	24,973	22,870	20,542	16,611	14,892
EBITDA Margin	69.73%	69.51%	70.04%	70.08%	68.91%	68.17%
D&A For EBITDA	1,178	1,034	943	861	804	767
EBIT	25,941	23,939	21,927	19,681	15,807	14,125
EBIT Margin	66.70%	66.63%	67.15%	67.15%	65.58%	64.66%
Effective Tax Rate	16.67%	17.45%	17.89%	17.53%	23.36%	21.20%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.